Cohort study reveals that early transcutaneous bilirubin kinetics predict phototherapy need in preterm infants, highlighting the value of rate-based monitoring for neonatal jaundice.
Background Preterm infants are vulnerable to bilirubin neurotoxicity. We evaluated whether time-stratified transcutaneous bilirubin (TcB) and kinetic indices improve the prediction of the risk of phototherapy and escalation. Methods In a cohort of preterm infants, only pre-phototherapy TcB values were analyzed. TcB values were grouped by postnatal age (≤24 h, 25–48 h, 49–72 h, ≥73 h), and sequential measurements were used to calculate bilirubin increase rates (RBIa, RBIb) and absolute percent change (APC%). Results Infants requiring phototherapy had higher TcB levels within 72 h, particularly at ≤24 h and 25–48 h. Independent predictors included TcB (OR 2.11), gestational age (OR 0.37), and postnatal age (OR 0.30; AUC 0.827). Treated infants showed faster bilirubin accumulation, and early RBIa correlated with peak TcB ( r = 0.334). APC% independently predicted proximity to the escalation threshold. Conclusions Time-standardized TcB measurements and dynamic kinetic indices may facilitate earlier identification of preterm infants at increased risk for phototherapy and warrant prospective validation.
No takes yet. Share an insight, caveat, or question.
Hegyi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: